(0.08%) 5 521.25 points
(0.11%) 39 889 points
(0.18%) 19 787 points
(0.02%) $81.65
(0.43%) $2.82
(-0.32%) $2 336.80
(-0.08%) $29.50
(0.30%) $1 004.80
(0.02%) $0.932
(0.03%) $10.54
(0.00%) $0.788
(-0.56%) $87.50
3.24% $ 4.14
Live Chart Being Loaded With Signals
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways...
Stats | |
---|---|
Dzisiejszy wolumen | 11 614 |
Średni wolumen | 10 206 |
Kapitalizacja rynkowa | 22.48M |
EPS | $-0.670 ( Q1 | 2024-05-14 ) |
Następna data zysków | ( $-0.640 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.260 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0810 (1.92%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Seizinger Bernd R. | Buy | 1 045 | Common Stock |
2024-06-20 | Seizinger Bernd R. | Buy | 4 185 | Stock Options (Right to Buy) |
2024-06-20 | Pamukcu Rifat | Buy | 1 045 | Common Stock |
2024-06-20 | Pamukcu Rifat | Buy | 4 185 | Stock Options (Right to Buy) |
2024-06-20 | Peters Richard | Buy | 4 185 | Stock Options (Right to Buy) |
INSIDER POWER |
---|
91.54 |
Last 96 transactions |
Buy: 12 961 904 | Sell: 911 966 |
Aprea Therapeutics Inc Korelacja
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aprea Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $583 231 |
Zysk brutto: | $576 178 (98.79 %) |
EPS: | $-3.95 |
FY | 2023 |
Przychody: | $583 231 |
Zysk brutto: | $576 178 (98.79 %) |
EPS: | $-3.95 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-186 445 (0.00 %) |
EPS: | $-2 714.18 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.740 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aprea Therapeutics Inc
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej